These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5338956)

  • 41. Evaluation of a new blood test for its potential to indicate leprosy infection prior to the appearance of clinical symptoms.
    Reich CV; Guinto RS; Cellona RV; Fajardo TT; Madarang MG
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):21-6. PubMed ID: 7195880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical evaluation studies in lepromatous leprosy. Sixth series: effect (on lepra reaction) of supplementing DDS with dexamethasone, methandrostenolone, or mefenamic acid.
    Doull JA; Tolentino JG; Guinto RS; Rodriguez JN; Leano LM; Fernandez JV; Rivera JN; Fajardo TT
    Int J Lepr Other Mycobact Dis; 1967; 35(2):128-39. PubMed ID: 5338957
    [No Abstract]   [Full Text] [Related]  

  • 43. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dimorphous leprosy].
    Esca SA; Zelger J
    Hautarzt; 1984 Jun; 35(6):298-302. PubMed ID: 6469634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of 9 months of treatment of lepromatous leprosy with desoxyfructo-serotonin].
    Saint-André P; Baquillon G; Mester de Parajd L; Mester de Parajd M
    Acta Leprol; 1982; (86-87):189-97. PubMed ID: 6815988
    [No Abstract]   [Full Text] [Related]  

  • 46. Leprosy: a close mimic in a rheumatology clinic.
    Samant R; Nadkar MY; Vaidya SS; Chhugani SJ; Balaji R; Borges NE
    J Assoc Physicians India; 1999 Jun; 47(6):576-9. PubMed ID: 10999151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lepsulmin in leprosy.
    Yawalkar SJ; Mardhekar BV; Aurangabadkar JW
    Bull Pharm Res Inst; 1968 Mar; 73():12-7. PubMed ID: 5695979
    [No Abstract]   [Full Text] [Related]  

  • 48. [Evaluation of the campaign against leprosy conducted by the Grandes Endémies du Cap-Vert sector in the Dakar urban area from 1975 to 1979].
    Husser JA
    Acta Leprol; 1983; 1(2):63-92. PubMed ID: 6356765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intravital studies of the bone marrow in malignant neoplasms with special reference to phase contrast microscopy].
    JESCHAL E
    Arch Geschwulstforsch; 1954; 7(2):138-48. PubMed ID: 13181425
    [No Abstract]   [Full Text] [Related]  

  • 50. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 51. The experimental properties of G 30 320 (B 663)--a new anti-leprotic agent.
    Vischer WA
    Lepr Rev; 1969 Apr; 40(2):107-10. PubMed ID: 5792376
    [No Abstract]   [Full Text] [Related]  

  • 52. Study of HLA-DR expression on skin lesions of leprosy before and during multiple drug therapy.
    Abdel Latif AM; Essa EA
    Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):104-10. PubMed ID: 12211894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical evaluation of Acacia catechu, Willd. (Khadira) in the treatment of lepromatous leprosy.
    Ojha D; Singh G; Upadhyaya YN
    Int J Lepr Other Mycobact Dis; 1969; 37(3):302-7. PubMed ID: 5393205
    [No Abstract]   [Full Text] [Related]  

  • 54. Improving patient compliance--a multicentre evaluation of the 'DDS tile test'.
    Naik SS; Vartak RR; Sequiera EB
    Indian J Lepr; 1994; 66(4):473-5. PubMed ID: 7714357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of viable organisms in leprosy patients treated with multidrug therapy.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
    Acta Leprol; 1999; 11(3):89-92. PubMed ID: 10544720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Initial results of prospective controlled treatment trials in leprosy].
    Pattyn SR
    Verh K Acad Geneeskd Belg; 1984; 46(3):207-19. PubMed ID: 6391013
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
    Molica S; Tucci L; Levato D; Docimo C
    Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of diversified antigens for detection of Mycobacterium leprae antibodies from leprosy patients and contacts.
    Singh NB; Bhatnagar S; Choudhary A; Gupta HP; Kaul SM
    Indian J Exp Biol; 1994 Jul; 32(7):478-81. PubMed ID: 7959924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leprosy coinfection with kala-azar.
    Rijal A; Rijal S; Bhandari S
    Int J Dermatol; 2009 Jul; 48(7):740-2. PubMed ID: 19570081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.